ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,339, issued on July 1, was assigned to The Trustees of the University of Pennsylvania (Philadelphia).
"Bisaminoquinolines and bisaminoacridines compounds and methods of their use" was invented by Jeffrey Winkler (Wynnewood, Pa.) and Ravi K. Amaravadi (Media, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to bisaminoquinolines and bisaminoacridines as autophagy inhibitors for treating cancer and other disease states and conditions."
The patent was filed on May 24, 2020, under Application No. 17/613,648.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parse...